1. Circulating FK506 binding protein 51 mRNA expression in patients with pituitary adenomas.
- Author
-
Yang, Yingying, Babayan, Lilit, Mirzakhanian, Argishty, Sisliyan, Nvard, Zhang, Dongyun, Hurtado, Carolina, Zahid, Abdul, Bergsneider, Marvin, Kim, Won, Wang, Marilene B, and Heaney, Anthony P
- Subjects
Circulating biomarker ,Cushing disease ,FKBP5 ,Pituitary tumors ,Cancer ,Brain Disorders ,Clinical Research ,Genetics - Abstract
BackgroundFK506 binding protein 51 (FKBP5) is a co-chaperone regulator of the glucocorticoid receptor (GR). Recent studies have reported increased FKBP5 mRNA in the circulation from patients with Cushing disease (CD) which returned to comparable levels seen in healthy controls following successful trans-nasal trans-sphenoidal (TNTS) surgical corticotroph tumor removal. However, the expression of circulating FKBP5 mRNA levels in other pituitary tumor subtypes and its specificity to corticotroph tumors is unknown.MethodsPre-operative blood was collected from consecutive patients undergoing TNTS for pituitary tumors (n = 57) at our center between 2015 and 2019. Total RNA was isolated from whole blood using RiboPure blood RNA isolation kit and real-time qPCR was used to quantitate circulating FKBP5 mRNA expression.ResultsConsistent with the prior report, higher circulating FKBP5 mRNA levels were observed in 20 patients with CD prior to surgical tumor removal, compared to 21 healthy controls (p
- Published
- 2023